Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 59Terminated 27Active not recruiting 25Recruiting 18Unknown 11Withdrawn 5Not yet recruiting 4Suspended 1

Sponsor Class

OTHER 4NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Neoplasms 1Mesothelioma 1Lung Neoplasms 1

Interventions

Paclitaxel 5Gemcitabine 3Nivolumab 2Injections 2E 7107 2Docetaxel 2Carboplatin 2Antibodies, Monoclonal 2130-nm albumin-bound paclitaxel 2venetoclax 1trastuzumab biosimilar HLX02 1taxane 1spartalizumab 1resiniferatoxin 1poly(I).poly(c12,U) 1pegamotecan 1palbociclib 1lenvatinib 1imisopasem manganese 1icotinib 1gusacitinib 1famitinib 1eniluracil 1dabrafenib 1cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1cobimetinib 1brincidofovir 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1aldesleukin 1abivertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × INDUSTRY × Etoposide × Clear all
NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡